This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing folate lipid used for conjugating antibodies, peptides and proteins through click chemistry in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing succinyl lipid for conjugatio...Encapsula NanoSciences
This document provides a material safety data sheet for IMMUNODOX-SUCCINYL-CONTROL. It lists the product and company identification, composition, hazards identification, first aid measures, fire fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. The product contains water, sucrose, histidine, ammonium sulfate, lipids, and polyethylene glycol lipids. It presents no significant health, flammability or reactivity hazards.
MSDS for PEGylated control liposomes containing Cyanur lipid for conjugation_...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Cyanur lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing PDP lipid for conjugation_IMM...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing PDP lipid used for conjugating antibodies, peptides and proteins from sulfur in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Amine lipid for conjugation_I...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Amine lipid used for conjugating antibodies, peptides and proteins from C-terminus in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Azide lipid for conjugation_I...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing azide lipid used for conjugating antibodies, peptides and proteins through click chemistry in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Aldehyde lipid for conjugatio...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Aldehyde lipid used for conjugating antibodies, peptides and proteins through a modified antibody in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Carboxylic Acid lipid for con...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Carboxylic Acid lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Folate lipid for conjugation_...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing folate lipid used for making liposomes that targeting folate receptors.
MSDS for PEGylated control liposomes containing succinyl lipid for conjugatio...Encapsula NanoSciences
This document provides a material safety data sheet for IMMUNODOX-SUCCINYL-CONTROL. It lists the product and company identification, composition, hazards identification, first aid measures, fire fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. The product contains water, sucrose, histidine, ammonium sulfate, lipids, and polyethylene glycol lipids. It presents no significant health, flammability or reactivity hazards.
MSDS for PEGylated control liposomes containing Cyanur lipid for conjugation_...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Cyanur lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing PDP lipid for conjugation_IMM...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing PDP lipid used for conjugating antibodies, peptides and proteins from sulfur in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Amine lipid for conjugation_I...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Amine lipid used for conjugating antibodies, peptides and proteins from C-terminus in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Azide lipid for conjugation_I...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing azide lipid used for conjugating antibodies, peptides and proteins through click chemistry in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Aldehyde lipid for conjugatio...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Aldehyde lipid used for conjugating antibodies, peptides and proteins through a modified antibody in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Carboxylic Acid lipid for con...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Carboxylic Acid lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Folate lipid for conjugation_...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing folate lipid used for making liposomes that targeting folate receptors.
MSDS for PEGylated control liposomes containing Maleimide lipid for conjugati...Encapsula NanoSciences
This document provides a material safety data sheet for IMMUNODOX-MALEIMIDE-CONTROL. It lists the product and company identification, composition, hazards identification, first aid measures, fire fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. The product contains mainly water along with sucrose, histidine, ammonium sulfate, and other ingredients in small percentages. It presents no known hazards according to OSHA and GHS standards.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing maleimide reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free sulfur in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Biotin lipid used for conjugating antibodies, peptides and proteins through biotinylation in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing Biotin PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered avidin in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...Encapsula NanoSciences
This material safety data sheet provides information on IMMUNODOX-NHS, which contains doxorubicin hydrochloride. It is classified as harmful if swallowed or inhaled and may cause cancer. Personal protective equipment including gloves, goggles and protective clothing should be worn when handling. The product contains water as the main ingredient along with sucrose, histidine, ammonium sulfate and other compounds. It must be stored between 2-8°C and avoided exposure to light and moisture.
MSDS for PEGylated control liposomes containing NHS lipid for conjugation_IMM...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing NHS lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes.
This document provides a material safety data sheet for Doxosome, a nanoparticle drug delivery system containing doxorubicin. It lists the product and company identification, composition, hazards, first aid measures, fire fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. The main components are water, sucrose, histidine, ammonium sulfate, lipids, cholesterol, and doxorubicin hydrochloride. Doxosome may cause harm if inhaled, absorbed, ingested, or gets in contact with eyes or skin. Proper personal protective equipment
MSDS for Non-PEGylated liposomes containing Caproylamine lipid for conjugatio...Encapsula NanoSciences
This document provides safety information about a product called IMMUNODOX-NP-CAPROYLAMINE (Vial 1 of 3). It lists the product name and company details. It describes the product composition and identifies the main ingredients as water, sodium dihydrogen citrate, phospholipids and cholesterol. It rates the product as having no known health, flammability or reactivity hazards. It provides first aid measures and safety handling instructions.
MSDS for Non-PEGylated liposomes containing Dodecanylamine lipid for conjugat...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing dodecanylamine lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing MCC lipid for conjugation_IMMUNOD...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing MCC lipid used for conjugating antibodies, peptides and proteins from sulfur in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing Glutaryl lipid for conjugation_IM...Encapsula NanoSciences
This document is a material safety data sheet that provides information about a product called IMMUNODOX-NP- GLUTARYL (Vial 1 of 3). It lists the product and company identification, composition, hazards identification, first aid measures, fire fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. The product contains water, sodium dihydrogen citrate, L-α-phosphatidylcholine, cholesterol, and 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosph
MSDS for Non-PEGylated liposomes containing PDP lipid for conjugation_IMMUNOD...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing PDP lipid used for conjugating antibodies, peptides and proteins from sulfur in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing Dodecanyl lipid for conjugation_I...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing dodecanyl lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing MPB lipid for conjugation_IMMUNOD...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing MPB lipid used for conjugating antibodies, peptides and proteins from sulfur in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing Succinyl lipid for conjugation_IM...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing succinyl lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing NHS lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes.This formulation is part of a 3 vial kit.
Material Safety Data Sheet (MSDS) for Dermasome-Ubq (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Ubq (NE). The Dermasome-Ubq (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing Biotinyl Cap lipid used for conjugating antibodies, peptides and proteins through biotinylation in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing Biotinyl Cap lipid for conjugatio...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing Biotinyl Cap lipid used for conjugating antibodies, peptides and proteins through biotinylation in order to make immunoliposomes. This formulation is part of a 3 vial kit.
Material Safety Data Sheet (MSDS) for Dermasome (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome (NE). The Dermasome (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
O documento descreve Ruby e Ruby on Rails, apresentando suas principais características. Ruby é descrita como uma linguagem de programação dinâmica e de código aberto, com foco em simplicidade e produtividade. Já Ruby on Rails é apresentado como um framework para desenvolvimento web que permite escrever código de forma elegante seguindo convenções. O documento também lista alguns casos de uso populares de Ruby on Rails.
This document discusses a musical piece titled "Nocturne op Póstumo" composed by Frédéric Chopin. The piece is a nocturne, a musical form typically characterized by a lyrical style and dreamlike quality, composed by the famous Polish pianist and composer Frédéric Chopin.
MSDS for PEGylated control liposomes containing Maleimide lipid for conjugati...Encapsula NanoSciences
This document provides a material safety data sheet for IMMUNODOX-MALEIMIDE-CONTROL. It lists the product and company identification, composition, hazards identification, first aid measures, fire fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. The product contains mainly water along with sucrose, histidine, ammonium sulfate, and other ingredients in small percentages. It presents no known hazards according to OSHA and GHS standards.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing maleimide reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free sulfur in order to make immunoliposomes.
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing Biotin lipid used for conjugating antibodies, peptides and proteins through biotinylation in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing Biotin PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered avidin in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...Encapsula NanoSciences
This material safety data sheet provides information on IMMUNODOX-NHS, which contains doxorubicin hydrochloride. It is classified as harmful if swallowed or inhaled and may cause cancer. Personal protective equipment including gloves, goggles and protective clothing should be worn when handling. The product contains water as the main ingredient along with sucrose, histidine, ammonium sulfate and other compounds. It must be stored between 2-8°C and avoided exposure to light and moisture.
MSDS for PEGylated control liposomes containing NHS lipid for conjugation_IMM...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated control liposomes containing NHS lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes.
This document provides a material safety data sheet for Doxosome, a nanoparticle drug delivery system containing doxorubicin. It lists the product and company identification, composition, hazards, first aid measures, fire fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. The main components are water, sucrose, histidine, ammonium sulfate, lipids, cholesterol, and doxorubicin hydrochloride. Doxosome may cause harm if inhaled, absorbed, ingested, or gets in contact with eyes or skin. Proper personal protective equipment
MSDS for Non-PEGylated liposomes containing Caproylamine lipid for conjugatio...Encapsula NanoSciences
This document provides safety information about a product called IMMUNODOX-NP-CAPROYLAMINE (Vial 1 of 3). It lists the product name and company details. It describes the product composition and identifies the main ingredients as water, sodium dihydrogen citrate, phospholipids and cholesterol. It rates the product as having no known health, flammability or reactivity hazards. It provides first aid measures and safety handling instructions.
MSDS for Non-PEGylated liposomes containing Dodecanylamine lipid for conjugat...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing dodecanylamine lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing MCC lipid for conjugation_IMMUNOD...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing MCC lipid used for conjugating antibodies, peptides and proteins from sulfur in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing Glutaryl lipid for conjugation_IM...Encapsula NanoSciences
This document is a material safety data sheet that provides information about a product called IMMUNODOX-NP- GLUTARYL (Vial 1 of 3). It lists the product and company identification, composition, hazards identification, first aid measures, fire fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. The product contains water, sodium dihydrogen citrate, L-α-phosphatidylcholine, cholesterol, and 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosph
MSDS for Non-PEGylated liposomes containing PDP lipid for conjugation_IMMUNOD...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing PDP lipid used for conjugating antibodies, peptides and proteins from sulfur in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing Dodecanyl lipid for conjugation_I...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing dodecanyl lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing MPB lipid for conjugation_IMMUNOD...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing MPB lipid used for conjugating antibodies, peptides and proteins from sulfur in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing Succinyl lipid for conjugation_IM...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing succinyl lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing NHS lipid used for conjugating antibodies, peptides and proteins from N-terminus (or available amine) in order to make immunoliposomes.This formulation is part of a 3 vial kit.
Material Safety Data Sheet (MSDS) for Dermasome-Ubq (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Ubq (NE). The Dermasome-Ubq (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing Biotinyl Cap lipid used for conjugating antibodies, peptides and proteins through biotinylation in order to make immunoliposomes. This formulation is part of a 3 vial kit.
MSDS for Non-PEGylated liposomes containing Biotinyl Cap lipid for conjugatio...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for non-PEGylated liposomes containing Biotinyl Cap lipid used for conjugating antibodies, peptides and proteins through biotinylation in order to make immunoliposomes. This formulation is part of a 3 vial kit.
Material Safety Data Sheet (MSDS) for Dermasome (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome (NE). The Dermasome (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
O documento descreve Ruby e Ruby on Rails, apresentando suas principais características. Ruby é descrita como uma linguagem de programação dinâmica e de código aberto, com foco em simplicidade e produtividade. Já Ruby on Rails é apresentado como um framework para desenvolvimento web que permite escrever código de forma elegante seguindo convenções. O documento também lista alguns casos de uso populares de Ruby on Rails.
This document discusses a musical piece titled "Nocturne op Póstumo" composed by Frédéric Chopin. The piece is a nocturne, a musical form typically characterized by a lyrical style and dreamlike quality, composed by the famous Polish pianist and composer Frédéric Chopin.
O documento discute táticas de mídia, que são os detalhes das ações estratégicas de mídia. Ele explica que as táticas devem especificar programas, datas, horários, locais e posições de veiculação para atingir o maior público-alvo possível com o menor custo, cumprindo os objetivos estratégicos. Além disso, fornece exemplos de táticas como usar programas de alta audiência ou baixo custo por clique.
Este poema describe la vida como un libro en blanco que recibimos al nacer. Cada persona escribe su propia historia a través de las decisiones y experiencias de su vida. Al final, Dios leerá nuestra historia completa. Se nos anima a reflexionar sobre nuestro pasado, perdonarnos a nosotros mismos y a otros, y vivir cada día como si fuera el último para escribir páginas positivas en nuestro libro de la vida.
Experiências, Erros e Acertos no Desenvolvimento de Projeto ÁgeisRaphael Molesim
O documento apresenta lições aprendidas pelo autor em projetos ágeis, enfatizando a importância de (1) entregar valor ao cliente o mais rápido possível, (2) manter visibilidade do projeto para todos os envolvidos, e (3) adotar postura ágil constante para lidar com problemas e mudanças.
1) O documento discute a proposta de introduzir o ensino bilingue português-inglês nas escolas públicas portuguesas já no próximo ano letivo.
2) Especialistas em línguas apoiam a medida, mas pais e sindicatos de professores estão contra devido a preocupações com o sucesso escolar e falta de professores qualificados.
3) Um projeto piloto em escolas de Lisboa testará a viabilidade do ensino bilingue antes de uma possível implementação mais ampla.
O documento discute as orações de Deus e milagres. Ele explica que Deus atende orações de acordo com Sua vontade e poder, não necessariamente os desejos humanos. Também explora como os milagres demonstram o amor e compaixão de Deus pelo sofrimento humano, Sua autoridade sobre a natureza, e visam a glória de Deus e salvação. No entanto, milagres não devem ser usados por motivos egoístas ou de dependência.
El artista chino Ai Xuan nació en 1947 en la provincia de Hebei, China. Se graduó de la Academia Central de Bellas Artes en 1967, pero su educación se interrumpió durante la Revolución Cultural cuando fue enviado a trabajos forzados en una granja militar en el Tíbet entre 1969 y 1973. Esta experiencia en el Tíbet ha influenciado grandemente su trabajo artístico.
The document provides information about tender notice advertisement booking on the website www.tendernoticeads.com. It outlines the booking procedure which involves selecting the ad type, emailing the ad content, designing the ad, approving the ad, making payment, and releasing the ad. It encourages booking tender notice ads at discounted rates by contacting Mr. Suraj at the provided phone numbers and emails.
The document provides information about tender notice advertisement booking on the website www.tendernoticeads.com. It outlines the booking procedure which involves selecting the ad type, emailing the ad content, designing the ad, approving the ad, making payment, and releasing the ad. It encourages booking tender notice ads at discounted rates by contacting Mr. Suraj at the provided phone numbers and emails.
The document discusses the Latin American peasantry. It focuses on the hardships faced by rural farmers and laborers in Latin America. Their lives were difficult due to poverty and lack of rights and political representation.
The document provides information about tender notice advertisement booking through www.tendernoticeads.com. It outlines the booking procedure which includes selecting the ad type, emailing the ad content, designing the ad, approving the ad, making payment, and releasing the ad. It promotes discounted rates for ad booking and provides contact information including phone numbers and email to reach out for booking tender notice advertisements.
El documento resume un taller sobre el espíritu emprendedor. Define el espíritu emprendedor como la capacidad de las personas para superar obstáculos y lograr sus objetivos. Explica que gracias al espíritu emprendedor, los humanos han podido enfrentar retos, generar nuevas sociedades modernas e innovadoras, y conquistar nuevos mundos. Además, destaca la importancia del espíritu emprendedor para que las personas se valgan por sí mismas y no tengan miedo de salir adelante.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Timur Tsaku nació en Tashkent, Uzbekistán y se convirtió en instructor de arte en la Academia de Arte y Teatro de Tashkent después de regresar a su tierra natal en 1991. Luego regresó a Israel en 2001 para iniciar una nueva línea de obras basadas en el Antiguo Testamento, cuyas pinturas fueron adquiridas para las colecciones permanentes del Museo de Israel y la residencia presidencial en Jerusalén.
El cuento cuenta la historia de un soldadito de plomo que se enamora de una bailarina de plomo. A pesar de tener solo una pierna, se mantuvo firme. Cayó de una ventana y fue arrastrado por el agua hasta que lo arrojaron al fuego, donde se derritió hasta formar un corazón de plomo.
El documento describe fotografías tomadas en la Universidad de Florida de los elementos que componen bebidas como el vodka, la piña colada y el Martini seco. Las imágenes, producidas por Bevshots, muestran moléculas de azúcares y glucosa cristalizadas bajo el microscopio con colores vibrantes. Para tomar las fotos, dejaron secar muestras de cada bebida durante 4 semanas hasta 3 meses, capturando pequeñas obras de arte alcohólicas con una cámara de 35 mm. Bevshots
Este documento describe al artista peruano Guzmán Emilio Huanca Yanariko Aymara. Asistió a la Escuela de Bellas Artes de Arequipa, Perú de 1980 a 1991. El uso fuerte de la luz solar es evidente en su trabajo, ya que dice que "sin luz, mi trabajo no tendría vida". Captura la luz pasando por las viñas y el sol que describe todo en sus pinturas, inspirado por la luz constante de su ciudad natal de Arequipa.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing aldehyde PEGylated lipid used for conjugating antibodies, peptides and proteins through an available engineered hydrazide in order to make immunoliposomes.
Material Safety Data Sheet (MSDS) for Cosmesome-Ubq (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Cosmesome-Ubq (NE). The Cosmesome-Ubq (NE) formulation is composed of saturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing DBCO PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered azide through click chemistry in order to make immunoliposomes.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing carboxylic acid reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have free amine in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing PDP PEGylated lipid used for conjugating antibodies, peptides and proteins that have free sulfur in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing azide PEGylated lipid used for conjugating antibodies, peptides and proteins that have an engineered aldehyde in order to make immunoliposomes.
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing folate PEGylated lipid used for targeting folate receptors.
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...Encapsula NanoSciences
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing amine reactive PEGylated lipid used for conjugating antibodies, peptides and proteins that have cabroxylic acid in order to make immunoliposomes.
Material Safety Data Sheet (MSDS) for CosmoMix-Ubq. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Ubq. The CosmoMix-Ubq formulation is composed of saturated phospholipids.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing carboxylic acid reactive PEGylated lipid used for conjugating antibodies, peptides and proteins through reaction with reactive amine in order to make immunoliposomes.
This is the Material Safety Data Sheet (MSDS) for PEGylated liposomal doxorubicin containing succinyl reactive PEGylated lipid used for conjugating antibodies, peptides and proteins through reaction with reactive amine in order to make immunoliposomes.
Similar to MSDS for PEGylated control liposomes containing DBCO lipid for conjugation_IMMUNODOX_DBCO (IMD-2012) (11)
This safety data sheet provides information on Clodrosome, a white liquid dispersion manufactured by Encapsula NanoSciences LLC. It is comprised primarily of water along with sodium chloride, potassium chloride, phosphates, lipids, and clodronate. The document outlines proper handling, storage, exposure controls, fire protection measures, accidental release procedures, toxicological properties, disposal considerations, and regulatory information for the product.
Product Spec Sheet for DermaMix-ACE. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-ACE. The DermaMix-ACE formulation is composed of unsaturated phospholipids.
Product Spec Sheet for DermaMix-Ubq. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Ubq. The DermaMix-Ubq formulation is composed of unsaturated phospholipids.
DermaMixTM-Res is a fine powder formulation containing phospholipids, cholesterol, and resveratrol for use in cosmetic products. It can be added to other powder formulations during manufacturing or dissolved in solvents. The powder consists of phospholipids, cholesterol, and resveratrol in micron-sized particles less than 400 microns. It is intended to be used by cosmetic formulators in powder or liquid products.
Product Spec Sheet for DermaMix-Chol. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Chol. The DermaMix-Chol formulation is composed of unsaturated phospholipids.
DermaMixTM- ACE is a fine powder mixture of phospholipids, cholesterol, vitamins A, C and E that can be added to powder cosmetic formulations or dissolved in solvents. It is composed of a proprietary blend of unsaturated phospholipids and cholesterol in micron-sized powder form. The powder can be mixed with other ingredients or dissolved and emulsified for use in liquid formulations.
Product Spec Sheet for CosmoMix. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Ubq. The CosmoMix-Ubq formulation is composed of saturated phospholipids.
Product Spec Sheet for CosmoMix. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Res. The CosmoMix-Res formulation is composed of saturated phospholipids.
Product Spec Sheet for CosmoMix. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Chol. The CosmoMix-Chol formulation is composed of saturated phospholipids.
CosmoMixTM- ACE is a fine powder mixture of hydrogenated phospholipids, cholesterol, vitamins A, C and E. It is designed to be added to powder or liquid cosmetic formulations during manufacturing. The powder consists of micron-sized lipid particles that can be mixed with other powders or dissolved in solvents. It provides vitamins and helps formulate cosmetic products.
CosmesomeTM is a highly concentrated lipid formulation that forms nano-sized liposomes upon dilution with water. It is composed of phospholipids, vitamin A, vitamin E, and lipid-soluble vitamin C. When hydrated, the lipids spontaneously rearrange to form liposomes that can encapsulate both water-soluble and lipid-soluble active ingredients. The formulation must be heated above 65°C after hydration to allow the saturated lipids to properly form liposomes.
Material Safety Data Sheet (MSDS) for DermaMix-Ubq. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Ubq. The DermaMix-Ubq formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for DermaMix-Res. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Res. The DermaMix-Res formulation is composed of unsaturated phospholipids.
This material safety data sheet provides information on COSMO-MIXTM- Res, which contains 3,5,4-trihydroxy-trans-stilbene and L-α-phosphatidylcholine. It may cause eye, skin, or respiratory irritation upon contact. Proper personal protective equipment should be worn when handling. The product should be stored between 2-8°C and kept away from light, moisture, heat, and oxidizing agents.
Material Safety Data Sheet (MSDS) for DermaMix-Chol. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-Chol. The DermaMix-Chol formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for CosmoMix-Chol. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-Chol. The CosmoMix-Chol formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for DermaMix-ACE. Powderized unsaturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is DermaMix-ACE. The DermaMix-ACE formulation is composed of unsaturated phospholipids.
Material Safety Data Sheet (MSDS) for CosmoMix-ACE. Powderized saturated lipid formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is CosmoMix-ACE. The CosmoMix-ACE formulation is composed of saturated phospholipids.
Material Safety Data Sheet (MSDS) for Dermasome-Ubq (containing alcohol). Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Ubq. The Dermasome-Ubq formulation is composed of unsaturated phospholipids in the presence of ethanol. The proliposome formulation forms liposomes containing CoQ10 upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Material Safety Data Sheet (MSDS) for Dermasome-Res (NE) a Proliposome formulation manufactured by Encapsula NanoSciences that is used specifically in the cosmetic industry. The brand name is Dermasome-Res (NE). The Dermasome-Res (NE) formulation is composed of unsaturated phospholipids and it does not contain alcohol. The proliposome formulation forms liposomes containing reveratrol upon dilution with water. During the dilution process water soluble active ingredients can be encapsulated inside the liposomes or liposoluble active ingredients can be incorporated into the lipid bilayers.
Sexuality - Issues, Attitude and Behaviour - Applied Social Psychology - Psyc...PsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
The cost of acquiring information by natural selectionCarl Bergstrom
This is a short talk that I gave at the Banff International Research Station workshop on Modeling and Theory in Population Biology. The idea is to try to understand how the burden of natural selection relates to the amount of information that selection puts into the genome.
It's based on the first part of this research paper:
The cost of information acquisition by natural selection
Ryan Seamus McGee, Olivia Kosterlitz, Artem Kaznatcheev, Benjamin Kerr, Carl T. Bergstrom
bioRxiv 2022.07.02.498577; doi: https://doi.org/10.1101/2022.07.02.498577
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆Sérgio Sacani
Context. The early-type galaxy SDSS J133519.91+072807.4 (hereafter SDSS1335+0728), which had exhibited no prior optical variations during the preceding two decades, began showing significant nuclear variability in the Zwicky Transient Facility (ZTF) alert stream from December 2019 (as ZTF19acnskyy). This variability behaviour, coupled with the host-galaxy properties, suggests that SDSS1335+0728 hosts a ∼ 106M⊙ black hole (BH) that is currently in the process of ‘turning on’. Aims. We present a multi-wavelength photometric analysis and spectroscopic follow-up performed with the aim of better understanding the origin of the nuclear variations detected in SDSS1335+0728. Methods. We used archival photometry (from WISE, 2MASS, SDSS, GALEX, eROSITA) and spectroscopic data (from SDSS and LAMOST) to study the state of SDSS1335+0728 prior to December 2019, and new observations from Swift, SOAR/Goodman, VLT/X-shooter, and Keck/LRIS taken after its turn-on to characterise its current state. We analysed the variability of SDSS1335+0728 in the X-ray/UV/optical/mid-infrared range, modelled its spectral energy distribution prior to and after December 2019, and studied the evolution of its UV/optical spectra. Results. From our multi-wavelength photometric analysis, we find that: (a) since 2021, the UV flux (from Swift/UVOT observations) is four times brighter than the flux reported by GALEX in 2004; (b) since June 2022, the mid-infrared flux has risen more than two times, and the W1−W2 WISE colour has become redder; and (c) since February 2024, the source has begun showing X-ray emission. From our spectroscopic follow-up, we see that (i) the narrow emission line ratios are now consistent with a more energetic ionising continuum; (ii) broad emission lines are not detected; and (iii) the [OIII] line increased its flux ∼ 3.6 years after the first ZTF alert, which implies a relatively compact narrow-line-emitting region. Conclusions. We conclude that the variations observed in SDSS1335+0728 could be either explained by a ∼ 106M⊙ AGN that is just turning on or by an exotic tidal disruption event (TDE). If the former is true, SDSS1335+0728 is one of the strongest cases of an AGNobserved in the process of activating. If the latter were found to be the case, it would correspond to the longest and faintest TDE ever observed (or another class of still unknown nuclear transient). Future observations of SDSS1335+0728 are crucial to further understand its behaviour. Key words. galaxies: active– accretion, accretion discs– galaxies: individual: SDSS J133519.91+072807.4
Candidate young stellar objects in the S-cluster: Kinematic analysis of a sub...Sérgio Sacani
Context. The observation of several L-band emission sources in the S cluster has led to a rich discussion of their nature. However, a definitive answer to the classification of the dusty objects requires an explanation for the detection of compact Doppler-shifted Brγ emission. The ionized hydrogen in combination with the observation of mid-infrared L-band continuum emission suggests that most of these sources are embedded in a dusty envelope. These embedded sources are part of the S-cluster, and their relationship to the S-stars is still under debate. To date, the question of the origin of these two populations has been vague, although all explanations favor migration processes for the individual cluster members. Aims. This work revisits the S-cluster and its dusty members orbiting the supermassive black hole SgrA* on bound Keplerian orbits from a kinematic perspective. The aim is to explore the Keplerian parameters for patterns that might imply a nonrandom distribution of the sample. Additionally, various analytical aspects are considered to address the nature of the dusty sources. Methods. Based on the photometric analysis, we estimated the individual H−K and K−L colors for the source sample and compared the results to known cluster members. The classification revealed a noticeable contrast between the S-stars and the dusty sources. To fit the flux-density distribution, we utilized the radiative transfer code HYPERION and implemented a young stellar object Class I model. We obtained the position angle from the Keplerian fit results; additionally, we analyzed the distribution of the inclinations and the longitudes of the ascending node. Results. The colors of the dusty sources suggest a stellar nature consistent with the spectral energy distribution in the near and midinfrared domains. Furthermore, the evaporation timescales of dusty and gaseous clumps in the vicinity of SgrA* are much shorter ( 2yr) than the epochs covered by the observations (≈15yr). In addition to the strong evidence for the stellar classification of the D-sources, we also find a clear disk-like pattern following the arrangements of S-stars proposed in the literature. Furthermore, we find a global intrinsic inclination for all dusty sources of 60 ± 20◦, implying a common formation process. Conclusions. The pattern of the dusty sources manifested in the distribution of the position angles, inclinations, and longitudes of the ascending node strongly suggests two different scenarios: the main-sequence stars and the dusty stellar S-cluster sources share a common formation history or migrated with a similar formation channel in the vicinity of SgrA*. Alternatively, the gravitational influence of SgrA* in combination with a massive perturber, such as a putative intermediate mass black hole in the IRS 13 cluster, forces the dusty objects and S-stars to follow a particular orbital arrangement. Key words. stars: black holes– stars: formation– Galaxy: center– galaxies: star formation
BIRDS DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptxgoluk9330
Ahota Beel, nestled in Sootea Biswanath Assam , is celebrated for its extraordinary diversity of bird species. This wetland sanctuary supports a myriad of avian residents and migrants alike. Visitors can admire the elegant flights of migratory species such as the Northern Pintail and Eurasian Wigeon, alongside resident birds including the Asian Openbill and Pheasant-tailed Jacana. With its tranquil scenery and varied habitats, Ahota Beel offers a perfect haven for birdwatchers to appreciate and study the vibrant birdlife that thrives in this natural refuge.
PPT on Alternate Wetting and Drying presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
PPT on Direct Seeded Rice presented at the three-day 'Training and Validation Workshop on Modules of Climate Smart Agriculture (CSA) Technologies in South Asia' workshop on April 22, 2024.
ESA/ACT Science Coffee: Diego Blas - Gravitational wave detection with orbita...Advanced-Concepts-Team
Presentation in the Science Coffee of the Advanced Concepts Team of the European Space Agency on the 07.06.2024.
Speaker: Diego Blas (IFAE/ICREA)
Title: Gravitational wave detection with orbital motion of Moon and artificial
Abstract:
In this talk I will describe some recent ideas to find gravitational waves from supermassive black holes or of primordial origin by studying their secular effect on the orbital motion of the Moon or satellites that are laser ranged.
Anti-Universe And Emergent Gravity and the Dark UniverseSérgio Sacani
Recent theoretical progress indicates that spacetime and gravity emerge together from the entanglement structure of an underlying microscopic theory. These ideas are best understood in Anti-de Sitter space, where they rely on the area law for entanglement entropy. The extension to de Sitter space requires taking into account the entropy and temperature associated with the cosmological horizon. Using insights from string theory, black hole physics and quantum information theory we argue that the positive dark energy leads to a thermal volume law contribution to the entropy that overtakes the area law precisely at the cosmological horizon. Due to the competition between area and volume law entanglement the microscopic de Sitter states do not thermalise at sub-Hubble scales: they exhibit memory effects in the form of an entropy displacement caused by matter. The emergent laws of gravity contain an additional ‘dark’ gravitational force describing the ‘elastic’ response due to the entropy displacement. We derive an estimate of the strength of this extra force in terms of the baryonic mass, Newton’s constant and the Hubble acceleration scale a0 = cH0, and provide evidence for the fact that this additional ‘dark gravity force’ explains the observed phenomena in galaxies and clusters currently attributed to dark matter.
Signatures of wave erosion in Titan’s coastsSérgio Sacani
The shorelines of Titan’s hydrocarbon seas trace flooded erosional landforms such as river valleys; however, it isunclear whether coastal erosion has subsequently altered these shorelines. Spacecraft observations and theo-retical models suggest that wind may cause waves to form on Titan’s seas, potentially driving coastal erosion,but the observational evidence of waves is indirect, and the processes affecting shoreline evolution on Titanremain unknown. No widely accepted framework exists for using shoreline morphology to quantitatively dis-cern coastal erosion mechanisms, even on Earth, where the dominant mechanisms are known. We combinelandscape evolution models with measurements of shoreline shape on Earth to characterize how differentcoastal erosion mechanisms affect shoreline morphology. Applying this framework to Titan, we find that theshorelines of Titan’s seas are most consistent with flooded landscapes that subsequently have been eroded bywaves, rather than a uniform erosional process or no coastal erosion, particularly if wave growth saturates atfetch lengths of tens of kilometers.
Mending Clothing to Support Sustainable Fashion_CIMaR 2024.pdfSelcen Ozturkcan
Ozturkcan, S., Berndt, A., & Angelakis, A. (2024). Mending clothing to support sustainable fashion. Presented at the 31st Annual Conference by the Consortium for International Marketing Research (CIMaR), 10-13 Jun 2024, University of Gävle, Sweden.
Gadgets for management of stored product pests_Dr.UPR.pdf
MSDS for PEGylated control liposomes containing DBCO lipid for conjugation_IMMUNODOX_DBCO (IMD-2012)
1. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
1. PRODUCT AND COMPANY IDENTIFICATION
Product name: IMMUNODOX
TM
-DBCO-CONTROL
Product Number: IMD-2012
Brand: IMMUNODOXTM
Company Address: ENCAPSULA NANOSCIENCES LLC
6 CADILLAC DRIVE SUITE 245
BRENTWOOD, TN, 37027
Technical Phone: 615-884-4442
Fax: 615-250-8747
Emergency Phone: 615-438-8553
2. COMPOSITION/INFORMATION ON INGREDIENTS
Ingredient Name CAS# Percent
WATER 7732-18-5 >90
SUCROSE 57-50-1 <5
HISTIDINE 71-00-1 <5
AMMONIUM SULFATE 7783-20-2 <5
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 <5
CHOLESTEROL 57-88-5 <5
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium
salt)
474922-77-5 <5
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[dibenzocyclooctyl(polyethylene glycol)-2000]
(ammonium salt)
N/A <5
3. HAZARDS IDENTIFCATION
OSHA
No known OSHA hazards.
GHS LABEL ELEMENTS, INCLUDING PRECAUTIONARY STATEMENTS
Not a hazardous mixture of substance.
HMIS RATING
HEALTH HAZARDS: 0
FLAMMABILITY: 0
CHRONIC HEALTH HAZARDS: 0
PHYSICAL HAZARDS: 0
2. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
NFPA RATING
HEALTH HAZARD: 0
FLAMMABILTY: 0
REACTIVITY: 0
POTENTIAL HEALTH EFFECTS
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Ingestion May be harmful if swallowed.
4. FIRST AID MEASURES
ORAL EXPOSURE
Do not induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with
water. Consult a physician
INHALATION EXPOSURE
If inhaled, remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give
oxygen. Consult a physician.
DERMAL EXPOSURE
In case of contact, immediately wash skin with soap and copious amounts of water. Contact a
physician.
EYE EXPOSURE
In case of contact, immediately flush eyes with copious amounts of water for at least 15 minutes.
Contact a physician.
5. FIRE FIGHTING MEASURES
FLAMMABILITY
Not flammable or combustible
EXTINGUISHING MEDIA
It is suitable to use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
SPECIAL PROCTECTIVE EQUIPMENT FOR FIRE-FIGHTERS
Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and
eyes.
HAZARDOUS COMBUSTION PRODUCTS
Hazardous decomposition products formed under fire conditions. Carbon oxides, nitrogen oxides,
sulphur oxides
3. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
6. ACCIDENTAL RELEASE MEASURES
METHODS FOR CLEANING UP
Absorb any spilled material quickly using absorbent pads. Wipe area to remove as much of the
liquid as possible. Apply bleach to the affected area and let sit for several hours. Clean the affected
area thoroughly with soap and water to remove the bleach. Collect all clean up materials and
dispose of them in accordance with local, state and federal waste disposal laws.
ENVIRONMENTAL PRECAUTIONS
Do not let product enter drains. If safe to do so prevent further leakages or spills.
PERSONAL PRECAUTIONS
Use personal protective equipment. Avoid breathing in vapors, mist or gas. Ensure adequate
ventilation. Prepare evacuation sites.
7. HANDLING AND STORAGE
HANDLING
User Exposure: Do not breathe vapor. Do not get in eyes, on skin, on clothing. Wash hands
thoroughly after handling.
STORAGE
Suitable: Keep tightly container closed. Store in temperature between approximately 2-8
o
C. Do not
freeze.
8. EXPOSURE CONTROLS/ PERSONAL PROTECTION
ENGINEERING CONTROLS
Appropriate industrial hygiene.
PERSONAL PROTECTIVE EQUIPMENT
Respiratory: Where protection is desired, use respirators and components tested and approved
under appropriate government standards such as NIOSH (US) or CEN (EU).
Hand: Compatible chemical-resistant gloves
Eye: Where protection is desired, use chemical safety goggles with side shades conforming to
EN166.
Skin and Body: Wear a complete suit protecting against chemicals, if desired.
GENERAL HYGIENE MEASURES
Wash hands thoroughly after handling. Wash contaminated clothing before reuse.
4. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
translucent
Safety data
N/A
Melting point
N/A
Boiling point
N/A
Flash point
N/A
Ignition Temperature
N/A
Lower explosion limit
N/A
Upper Explosion limit
N/A
Water Solubility
N/A
Density
N/A
10. STABILITY AND REACITIVITY
STORAGE STABILITY
Store under recommended conditions.
MATERIALS TO AVIOD
Strong oxidizing agents
HAZARDOUS DECOMPOSITION PRODUCTS
Hazardous decomposition products formed under fire conditions- Carbon oxides, nitrogen
oxides, sulphur oxides.
11. TOXICOLOGICAL INFORMATION
IARC: No component of this product present at levels greater than or equal to 0.1% is
identified as probable, possible or confirmed human carcinogen by the IARC.
OHSA: No component of this product present at levels greater than or equal to 0.1% is
identified as probable, possible or confirmed human carcinogen by the OHSA.
5. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
ACGIH: No component of this product present at levels greater than or equal to 0.1% is
identified as probable, possible or confirmed human carcinogen by the ACGIH.
EPA: No component of this product present at levels greater than or equal to 0.1% is
identified as probable, possible or confirmed human carcinogen by the EPA.
ACUTE TOXICITY
No data available
Irritation and Corrosion
No data available
ROUTE OF EXPOSURE
Skin Contact: May cause skin irritation
Skin Absorption: May be harmful if absorbed through the skin
Eye Contact: May Cause eye irritation
Inhalation: Materials may be irritating to mucous membranes and upper respiratory tract.
Ingestion: May be harmful if swallowed
SIGNS AND SYMPTOMS OF EXPOSURE
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
12. ECOLOGICAL INFORMATION
Elimination information (persistence and degradability)
N/A
Ecotoxicity effects
N/A
Further information on ecology
N/A
13. DISPOSAL CONSIDERATIONS
PRODUCT
Observe all federal, state, and local environment regulations. Contact a licensed professional waste
disposal service to remove this material.
CONTAMINATED PACKAGING
Dispose of as unused product.
6. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
14. TRANSPROT INFORMATION
DOT (US)
Not dangerous goods
IMDG
Not dangerous goods
IATA
Not dangerous goods
15. REGULATORY INFORMATION
OSHA HAZARDS
No known OSHA hazards
SARA 302 COMPONENTS
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title
III, Section 302
SARA 313 COMPONENTS
SARA 313: This material does not contain any chemical components with known CAS numbers
that exceed threshold (De Minimis) reporting levels established be SARA Title III, Section 313
SARA 311/312 HAZARDS
No SARA hazards
MASSACHUSETTS RIGHT TO KNOW COMPONENTS
CAS-No. Revision Date
AMMONIUM SULFATE 7783-20-2 1993-04-24
SUCROSE 57-50-1 1991-07-01
PENNSYVANIA RIGHT TO KNOW COMPONENTS
CAS-No. Revision Date
AMMONIUM SULFATE 7783-20-2 1993-04-24
SUCROSE 57-50-1 1991-07-01
L-HISTDINE 71-00-1
CHOLESTEROL 57-88-5
WATER 7732-18-5
7. Material Safety Data Sheet
Version 1.1
Revision Date: 06/05/2014
Print Date: 08/06/2014
NEW JERSEY RIGHT TO KNOW COMPONENTS
CAS-No. Revision Date
AMMONIUM SULFATE 7783-20-2 1993-04-24
SUCROSE 57-50-1 1991-07-01
L-HISTDINE 71-00-1
CHOLESTEROL 57-88-5
WATER 7732-18-5
CALIFORNIA PROP. 65 COMPONENTS
This product does not contain any chemicals known to the state of CA to cause cancer, birth, or
other reproductive defects.
16. OTHER INFORMATION
Copyright 2013 Encapsula NanoSciences LLC license granted to make unlimited paper copies for internal
use only.
The above information is believed to be correct but does not support to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Encapsula NanoSciences LLC shall not be held liable for any
damage resulting from handling or from contact with the above product.